Losartan Induced Fetal Toxicity

Indian Journal of Pediatrics

Volumn 70, Issue 11, 2003, Pages 923-924

  Nayar, Bonilla ^a   Singhal, Ashwani ^a   Aggarwal, Rajiv ^a   Malhotra, Neena ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Angiotensin II receptor antagonist; Fetal toxicity; Losartan; Transient oliguria

Indexed keywords

LOSARTAN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; FEEDING BEHAVIOR; FEMALE; HUMAN; MALE; OLIGURIA; OSSIFICATION; PRENATAL EXPOSURE; SKULL; TERATOGENICITY; TREATMENT PLANNING;

EID: 0346252191     PISSN: 00195456     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02730601     Document Type: Article

References (6)

1. Saji H, Yamanaker M, Hagiwara A, Jjeri R. Losartan and fetal toxic effects. Lancet 2001; 357: 363.
2. Sorensen AM, Christensen S, Jonassen TE, Andersen D, Petersen JS. Teratogenic effects of ACE-inhibitors and Angiotensin II receptor antagonists (Article in Danish). Ugeker Laegar Mar 2; 160(1): 1460-1464.
3. Stevenson KM, Gibson KJ, Lumbers ER. Effects of Losartan on the cardiovascular system, renal haemodynamics and function and lung liquid flow in fetal sheep. Clin Exp Pharmacol Physiol 1996; 23: 125-133.
4. Lambot MA, Vermeyten D, Noel JC. Angiotensin-II receptor inhibitors in pregnancy. Lancet 2001; 357: 1619-1620.
5. Hinsberger A, Wingen AM, Hoyer PF. Angiotensin II receptor inhibitors in pregnancy. Lancet 2001; 357: 1620.
6. Chung NA, Lip GHH, Beevers M, Beevers DG. Angiotensin II receptor inhibitors in pregnancy. Lancet 2001; 357: 1620.